Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
about
A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersAberrant crypt foci as microscopic precursors of colorectal cancer.Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics.Chemoprevention of 1,2-dimethylhydrazine-induced colonic preneoplastic lesions in Fischer rats by 6-methylsulfinylhexyl isothiocyanate, a wasabi derivative.Cellular membranes function as a storage compartment for celecoxib.Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.Histological and immunohistochemical observations of mucin-depleted foci (MDF) stained with Alcian blue, in rat colon carcinogenesis induced with 1,2-dimethylhydrazine dihydrochloride.Effect of concomitant polyethylene glycol and celecoxib on colonic aberrant crypt foci and tumors in F344 rats.Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice.
P2860
Q26739665-0CFC0605-E5E0-443E-8D73-EDC26E861578Q35605612-640DAB08-3747-472A-B395-6AB10784839DQ35912455-31E77113-BF17-49F4-AAD8-1805440B3316Q36216641-5BCB5E75-56EA-4DE8-8103-FC0E17BCB6C5Q39819038-859C3B48-1DC3-4527-BDD3-2E27FEB4B788Q43942746-EF4C65BA-E035-4108-B312-1D5BBA53556EQ45123695-4E654BF0-3756-4891-A5B6-625B054AD62EQ46621553-C361B8CE-C777-47A6-B69E-B4CD10071A9AQ47795769-D1323303-671F-462B-A560-F41599A7B967
P2860
Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@en
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@nl
type
label
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@en
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@nl
prefLabel
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@en
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@nl
P2093
P2860
P1476
Suppression of occurrence and ...... genase-2 inhibitor, celecoxib.
@en
P2093
M Katayama
P2860
P304
P356
10.1111/J.1349-7006.2001.TB01139.X
P577
2001-06-01T00:00:00Z